Additionally, a protein chaperone, heat-shock protein 90 (HSP90), has been shown to interact with and stabilize TYK2 and other JAKs in cancer cells, and thus is a promising therapeutic target [36,65]. The gene discussed is TYK2; the disease is cancer.